Author

K. Loh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Moreno-Asso· 1 shared C. Smith· 1 shared C.-H. Yang· 1 shared D. Ann-Onda· 1 shared D. L. Eizirik· 1 shared D. Lanbe· 1 shared D. R. Richardson· 1 shared D.-H. Bae· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Moreno-Asso

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Melanotransferrin Functions as a Pro-Oncogenic WNT Agonist: A Yin-Yang Relationship in Melanoma with the WNT Antagonist and Metastasis Suppressor, NDRG1

D. R. Richardson, J. Paluncic, M. Gholam Azad, D. Lanbe, J. Skoda, K. Park, S. Chiang, D.-H. Bae, R. Scolyer, R. Afroz, G. Babu, J. Wilmott, K. Loh, P. Jansson, M. Dharmasivam, , Z. Kovacevic

This study identifies MTf as a pro-oncogenic WNT agonist that forms a bidirectional feedback loop with NDRG1, promoting melanoma progression and metastasis.

bioRxiv · Feb 27, 2023 · PreprintCancer Biology

Elevated Neuropeptide Y1 Receptor Signaling Contributes to β-cell Dysfunction and Failure in Type 2 Diabetes

C.-H. Yang, D. Ann-Onda, X. Lin, S. Fynch, S. Nadarajah, E. Pappas, X. Liu, J. Scott, J. S. Oakhill, S. Galic, Y. Shi, A. Moreno-Asso, C. Smith, T. Loudovaris, I. Levinger, , K. Loh

This study shows that increased neuropeptide Y1 receptor signaling contributes to β-cell dysfunction in type 2 diabetes and that inhibiting this receptor with BIBO3304 improves β-cell function and glycaemic control.

bioRxiv · May 14, 2021 · PreprintCell Biology